News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Satori Pharmaceuticals Shuts Down After Alzheimer Trial Failure


5/31/2013 9:30:25 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cambridge, MA-based Satori Pharmaceuticals has abruptly shut down due to issues with preclinical studies on its experimental treatment for Alzheimer’s disease.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy


comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES